143 results on '"Hauser, Stephen"'
Search Results
2. Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials
3. Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO
4. Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross‐Sectional and Gray Matter Areas
5. Reply to “Silent Progression or Bout Onset Progressive Multiple Sclerosis?”
6. Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
7. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
8. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease
9. B-cell Therapy for Multiple Sclerosis: Entering an era
10. Onset of secondary progressive MS after long‐term rituximab therapy – a case report
11. Advancing ethical neuroscience
12. 2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times
13. Precision medicine in chronic disease management: The multiple sclerosis BioScreen
14. Spinal cord gray matter atrophy correlates with multiple sclerosis disability
15. In vivo evidence of glutamate toxicity in multiple sclerosis
16. What ethics integration looks like in neuroscience research
17. In multiple sclerosis, oligoclonal bands connect to peripheral B‐cell responses
18. Quo vadis? - peering into the future
19. Have theAnnalseditors added value?
20. Reviewing how we review
21. Multiple sclerosis: Prospects and promise
22. Blockbusters for cheap? The difficulties surrounding generic biologics
23. Introduction to a special edition ofAnnals: Therapeutic prospects
24. Neurology: Violence at home
25. Living in the time of sequestration
26. The dangers of clinical conviction: An “M&M” of endovascular therapies for stroke
27. The neurologic revolving door: Time to pay attention to readmissions
28. Big neuroscience
29. Multiple sclerosis: Monotherapy rules
30. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis
31. Are relative value units hurting healthcare?
32. Reply to Dr Sethi
33. DSM‐V: Psychodrama on the public stage
34. Robert A. Fishman, MD
35. Electronic medical records and the academic neurologist: When carrots turn into sticks
36. Deciphering the signature injury
37. Healthcare costs: Eden's apple?
38. Beaten into action: A perspective on blood sports
39. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
40. Note to aspiring clinician scientists: Skies are clearing
41. Searching for novelty: Challenges with open access data
42. The genetics of multiple sclerosis: an up‐to‐date review
43. Florbetapir: Knowing one's future
44. Multiple sclerosis drugs: Sticker shock
45. Apping at the Annals
46. Modern care for neurological problems must address waste
47. Fighting decision fatigue
48. Decoding Multiple Sclerosis
49. Benefits of medical research: Hollywood weighs in
50. Global clinical trials: Challenges ahead
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.